Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Centene is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-08Current report (material event)
- 8-K2026-09-16Current report (material event)
- 8-K2026-08-17Current report (material event)
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-28Current report (material event)
- 10-Q2026-07-28Quarterly report
- 8-K2026-06-22Current report (material event)
- 8-K2026-05-15Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- 10-Q2026-04-28Quarterly report
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- DEFA14A2026-03-26DEFA14A
- DEF 14A2026-03-26Proxy statement
- 8-K2026-03-24Current report (material event)
- 8-K2026-03-10Current report (material event)
- 8-K2026-02-23Current report (material event)
- 10-K2026-02-17Annual report
- SCHEDULE 13G2026-02-13SCHEDULE 13G
- 8-K2026-02-06Current report (material event)
- 8-K2025-11-10Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-04SCHEDULE 13G/A
- 8-K2025-10-29Current report (material event)
- 10-Q2025-10-29Quarterly report
- 8-K2025-09-11Current report (material event)
- 8-K2025-08-15Current report (material event)
- SCHEDULE 13G/A2025-08-14SCHEDULE 13G/A
- 8-K2025-08-04Current report (material event)
- 8-K2025-07-25Current report (material event)
- 10-Q2025-07-25Quarterly report
- SCHEDULE 13G/A2025-07-16SCHEDULE 13G/A
- 8-K2025-07-01Current report (material event)
- S-82025-05-19Employee stock plan
- 8-K2025-05-14Current report (material event)
- SCHEDULE 13G2025-05-12SCHEDULE 13G
- 8-K2025-05-06Current report (material event)
- 8-K2025-04-25Current report (material event)
- 10-Q2025-04-25Quarterly report
- PX14A6G2025-04-14PX14A6G
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.